As direct-acting antivirals become more affordable, they also become accessible to more patients with hepatitis C, without treatment delays. These powerful drugs, which were once provided only to the sickest of HCV patients, are now a treatment option for HCV cases at all stages.
In 2016, the Department of Veteran’s Affairs (VA) received funding from Congress that would enable them to provide care for all veterans affected with HCV, regardless of stage.
“The VA felt compelled to treat every veteran with hepatitis C,” Macy Ho, PharmD, of the VA Long Beach Healthcare System told HCV Next. “Before, the only veterans who got these agents were people with advanced liver disease, cirrhosis. Since 2016, we are now able to treat everyone with [hepatitis] C regardless of stage of liver disease.”